Skip to main content
Journal cover image

Succinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: Effects of DHA supplementation.

Publication ,  Journal Article
Liu, X-J; Xie, L; Du, K; Liu, C; Zhang, N-P; Gu, C-J; Wang, Y; Abdelmalek, MF; Dong, W-Y; Liu, X-P; Niu, C; Yang, C; Diehl, AM; Wu, J
Published in: Liver Int
April 2020

BACKGROUND AND AIMS: Treatment of non-alcoholic steatohepatitis (NASH) is challenging, because suppressing fibrotic progression has not been achieved consistently by drug candidates currently in clinical trials. The aim of this study was to investigate the molecular interplays underlying NASH-associated fibrosis in a mouse NASH model and human specimens. METHODS: Mice were divided into 4 groups: Controls; NASH (high fat/Calorie diet plus high fructose and glucose in drinking water, HFCD-HF/G) for 16 weeks; HFCD-HF/G plus docosahexaenoic acid (DHA) for 16 or 8 weeks. RESULTS: Along with NASH progression, fibrotic deposition was documented in HFCD-HF/G-fed mice. Liver succinate content was significantly increased along with decreased expression of succinate dehydrogenase-A (SDH-A) in these mice; whereas, GPR-91 receptor expression was much enhanced in histology compared to control mice, and co-localized histologically with hepatic stellate cells (HSCs). Succinate content was increased in fatty acid-overloaded primary hepatocytes with significant oxidant stress and lipotoxicity. Exposure to succinate led to up-regulation of GPR-91 receptor in primary and immortalized HSCs. In contrast, suppression of GPR-91 receptor expression abolished succinate stimulatory role in GPR-91 expression and extracellular matrix production in HSCs. All these changes were minimized or abrogated by DHA supplementation in vivo or in vitro. Moreover, GPR-91 receptor expression correlates with severity of fibrosis in human NASH biopsy specimens. CONCLUSION: Succinate accumulation in steatotoic hepatocytes may result in HSC activation through GPR-91 receptor signalling in NASH progression, and the cross-talk between hepatocytes and HSC through GPR-91 signalling is most likely to be the molecular basis of fibrogenesis in NASH.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Liver Int

DOI

EISSN

1478-3231

Publication Date

April 2020

Volume

40

Issue

4

Start / End Page

830 / 843

Location

United States

Related Subject Headings

  • Succinic Acid
  • Non-alcoholic Fatty Liver Disease
  • Mice, Inbred C57BL
  • Mice
  • Liver
  • Gastroenterology & Hepatology
  • Fibrosis
  • Docosahexaenoic Acids
  • Dietary Supplements
  • Animals
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liu, X.-J., Xie, L., Du, K., Liu, C., Zhang, N.-P., Gu, C.-J., … Wu, J. (2020). Succinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: Effects of DHA supplementation. Liver Int, 40(4), 830–843. https://doi.org/10.1111/liv.14370
Liu, Xue-Jing, Li Xie, Kuo Du, Chang Liu, Ning-Ping Zhang, Chen-Jian Gu, Ying Wang, et al. “Succinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: Effects of DHA supplementation.Liver Int 40, no. 4 (April 2020): 830–43. https://doi.org/10.1111/liv.14370.
Liu, Xue-Jing, et al. “Succinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: Effects of DHA supplementation.Liver Int, vol. 40, no. 4, Apr. 2020, pp. 830–43. Pubmed, doi:10.1111/liv.14370.
Liu X-J, Xie L, Du K, Liu C, Zhang N-P, Gu C-J, Wang Y, Abdelmalek MF, Dong W-Y, Liu X-P, Niu C, Yang C, Diehl AM, Wu J. Succinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: Effects of DHA supplementation. Liver Int. 2020 Apr;40(4):830–843.
Journal cover image

Published In

Liver Int

DOI

EISSN

1478-3231

Publication Date

April 2020

Volume

40

Issue

4

Start / End Page

830 / 843

Location

United States

Related Subject Headings

  • Succinic Acid
  • Non-alcoholic Fatty Liver Disease
  • Mice, Inbred C57BL
  • Mice
  • Liver
  • Gastroenterology & Hepatology
  • Fibrosis
  • Docosahexaenoic Acids
  • Dietary Supplements
  • Animals